eli lilly phase 3 trial retatrutide Today, we shared new data from the latest study of retatrutide, an investigational treatment being studied for adults with obesity or overweight with at least one weight-related comorbidity. Learn more eli lilly phase 3 trial

Following the prescribed dose escalation schedule is crucialGLP-1 receptor agonists are typically initiated at low doses and gradually increased

Druckers lab at the University of Toronto has pivoted from studying chronic diseases like diabetes and obesity to unraveling the immune system effects of GLP-1s

Individuals with long-standing type 2 diabetes, particularly those with significant beta-cell dysfunction or complications, typically require longer-term treatment

That said, the quality of what you eat still matters, prioritizing protein and whole foods supports both the medications effects and your overall health

Umbrella Review Approach and Evidence Selection The researchers comprehensively assessed health outcomes associated with GLP-1RA treatment in patients with T2D

Looking at data, GLP-1s seem to turn down the skins ability to protect against sun damage, produce collagen and elastin, and repair itself, Few says